|
2026 Conference Publication Novel Bacteroides cellulosilyticus strain produces a small anti-inflammatory bioactive with therapeutic potential for inflammatory bowel diseaseMurtaza, Nida, Giri, Rabina, Schooth, Lauren, Salim, Angela, Capon, Rob, Morrison, Mark and Begun, Jakob (2026). Novel Bacteroides cellulosilyticus strain produces a small anti-inflammatory bioactive with therapeutic potential for inflammatory bowel disease. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2026, Perth, WA Australia, 28-31 August 2026. Richmond, VIC Australia: John Wiley & Sons. |
|
2026 Conference Publication Sa1435 PLATELET-ACTIVATING FACTOR RECEPTOR PRESENTS PHOSPHORYLCHOLINE TO TOLL-LIKE RECEPTOR 4 DURING COLITISSherwin, Simonne, Schooth, Lauren F., Liu, Gang, Soh, Wai Sinn, Pryor, Jennifer C., Burns, Grace L., Minahan, Kyra, Morrison, Mark and Keely, Simon (2026). Sa1435 PLATELET-ACTIVATING FACTOR RECEPTOR PRESENTS PHOSPHORYLCHOLINE TO TOLL-LIKE RECEPTOR 4 DURING COLITIS. Elsevier BV. doi: 10.1016/s0016-5085(26)02447-9 |
|
2026 Conference Publication Platelet-activating factor receptor presents phosphorylcholine to toll-like receptor 4 during colitisSherwin, Simonne, Schooth, Lauren F., Liu, Gang, Soh, Wai Sinn, Pryor, Jennifer C., Burns, Grace L., Minahan, Kyra, Morrison, Mark and Keely, Simon (2026). Sa1435 PLATELET-ACTIVATING FACTOR RECEPTOR PRESENTS PHOSPHORYLCHOLINE TO TOLL-LIKE RECEPTOR 4 DURING COLITIS. Gastrointestinal Endoscopy, 103 (5), S-930. doi: 10.1016/s0016-5107(26)02378-3 |
|
2026 Conference Publication Cloaking antibodies: a newly identified cause of Crohn’s disease inflammation and complications, a prognostic marker, and a treatment targetFeng, Wenkang, Tovey-Matthews, Abigail, Wright, Emily K., Hamilton, Amy L., Kang, Seungha, Davies, Julie, Lovett, Grace C., Schulberg, Julien D., Kamm, Michael A., Morrison, Mark and Wells, Timothy (2026). Cloaking antibodies: a newly identified cause of Crohn’s disease inflammation and complications, a prognostic marker, and a treatment target. Digestive Disease Week (DDW) 2026, Chicago, IL United States, 2-5 May 2026. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5107(26)02871-3 |
|
2026 Conference Publication Machine learning-driven integrated analysis of multinational microbial, diet and clinical data identifies the determinants of Crohn’s disease. The enigma studyYang, Wanyi, Zheng, Jiaying, Sun, Qianru, Kang, Seungha, Teh, Jingjie, Trakman, Gina L., Hamilton, Amy L., O’ Brien, Amy Wilson, Ching, Jessica Y., Sun, Yang, Chan, Francis K., Miao, Yinglei, Sung, Joseph JY, Morrison, Mark, Kamm, Michael A., Ng, Siew C. and Zhang, Jingwan (2026). 822 MACHINE LEARNING-DRIVEN INTEGRATED ANALYSIS OF MULTINATIONAL MICROBIAL, DIET AND CLINICAL DATA IDENTIFIES THE DETERMINANTS OF CROHN’S DISEASE. THE ENIGMA STUDY. Gastrointestinal Endoscopy, 103 (5), S-899. doi: 10.1016/s0016-5107(26)02310-2 |
|
2026 Conference Publication Su1485 THE RESISTOME OF THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA VARIES IN FORM AND FUNCTION BETWEEN THE EAST AND WEST, AND IN CROHN’S DISEASE AND HEALTH. THE ENIGMA STUDYKang, Seungha, Teh, Jingjie, Zhang, Jingwan, Zheng, Jiaying, Sun, Qianru, Yang, Wanyi, Hamilton, Amy L., Wilson-O’Brien, Amy, Trakman, Gina L., Ching, Jessica Y., Sung, Joseph JY, Ng, Siew C., Kamm, Michael A. and Morrison, Mark (2026). Su1485 THE RESISTOME OF THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA VARIES IN FORM AND FUNCTION BETWEEN THE EAST AND WEST, AND IN CROHN’S DISEASE AND HEALTH. THE ENIGMA STUDY. Elsevier BV. doi: 10.1016/s0016-5085(26)02692-2 |
|
2026 Conference Publication 822 MACHINE LEARNING-DRIVEN INTEGRATED ANALYSIS OF MULTINATIONAL MICROBIAL, DIET AND CLINICAL DATA IDENTIFIES THE DETERMINANTS OF CROHN’S DISEASE. THE ENIGMA STUDYYang, Wanyi, Zheng, Jiaying, Sun, Qianru, Kang, Seungha, Teh, Jingjie, Trakman, Gina L., Hamilton, Amy L., O’ Brien, Amy Wilson, Ching, Jessica Y., Sun, Yang, Chan, Francis K., Miao, Yinglei, Sung, Joseph JY, Morrison, Mark, Kamm, Michael A., Ng, Siew C. and Zhang, Jingwan (2026). 822 MACHINE LEARNING-DRIVEN INTEGRATED ANALYSIS OF MULTINATIONAL MICROBIAL, DIET AND CLINICAL DATA IDENTIFIES THE DETERMINANTS OF CROHN’S DISEASE. THE ENIGMA STUDY. Elsevier BV. doi: 10.1016/s0016-5085(26)02379-6 |
|
2026 Conference Publication Emulsifier polysorbate 80 exhibits distinct degradation in Crohn’s disease mediated by altered gut microbiome. The enigma studyZhang, Jingwan, Tang, Xinyi, Hao, Fangjia, Kang, Seungha, Teh, Jing Jie, Trakman, Gina L., Zheng, Jiaying, SUN, Qianru, Liu, Yingzhi, Hamilton, Amy L., O’ Brien, Amy Wilson, Ching, Jessica Y., Sun, Yang, Zhang, Lin, Miao, Yinglei, Chan, Francis K., Sung, Joseph JY, Morrison, Mark, Kamm, Michael A. and Ng, Siew C. (2026). Mo1618 EMULSIFIER POLYSORBATE 80 EXHIBITS DISTINCT DEGRADATION IN CROHN’S DISEASE MEDIATED BY ALTERED GUT MICROBIOME. THE ENIGMA STUDY. Gastrointestinal Endoscopy, 103 (5), S-1213. doi: 10.1016/s0016-5107(26)02988-3 |
|
2026 Conference Publication Cloaking antibodies: a newly identified cause of Crohn’s disease inflammation and complications, a prognostic marker, and a treatment targetFeng, Wenkang, Tovey-Matthews, Abigail, Wright, Emily K., Hamilton, Amy L., Kang, Seungha, Davies, Julie, Lovett, Grace C., Schulberg, Julien D., Kamm, Michael A., Morrison, Mark and Wells, Timothy (2026). Cloaking antibodies: a newly identified cause of Crohn’s disease inflammation and complications, a prognostic marker, and a treatment target. Digestive Disease Week (DDW) 2026, Chicago, IL United States, 2-5 May 2026. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(26)02940-9 |
|
2026 Conference Publication The resistome of the colonic mucosa-associated microbiota varies in form and function between the east and west, and in Crohn’s disease and health. The enigma studyKang, Seungha, Teh, Jingjie, Zhang, Jingwan, Zheng, Jiaying, Sun, Qianru, Yang, Wanyi, Hamilton, Amy L., Wilson-O’Brien, Amy, Trakman, Gina L., Ching, Jessica Y., Sung, Joseph JY, Ng, Siew C., Kamm, Michael A. and Morrison, Mark (2026). Su1485 THE RESISTOME OF THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA VARIES IN FORM AND FUNCTION BETWEEN THE EAST AND WEST, AND IN CROHN’S DISEASE AND HEALTH. THE ENIGMA STUDY. Gastrointestinal Endoscopy, 103 (5), S-1041. doi: 10.1016/s0016-5107(26)02623-4 |
|
2026 Conference Publication Faecal microbiota transplantation for active cCrohn’s disease: the miro (microbial restoration) randomised placebo-controlled trialFehily, Sasha R., Wright, Emily K., Bogatic, Damjana, O’ Brien, Amy Wilson, Basnayake, Chamara, Stanley, Annalise, Marks, Elise, Russell, Erin, Yuwei, Rong, Gory, Ilana, Ardalan, Zaid, Hamilton, Amy L., Morrison, Mark, Thompson, Alexander, Bryant, Robert V., Costello, Samuel and Kamm, Michael A. (2026). 729 FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE CROHN’S DISEASE: THE MIRO (MICROBIAL RESTORATION) RANDOMISED PLACEBO-CONTROLLED TRIAL. Gastrointestinal Endoscopy, 103 (5), S-895. doi: 10.1016/s0016-5107(26)02303-5 |
|
2026 Conference Publication Mo1618 EMULSIFIER POLYSORBATE 80 EXHIBITS DISTINCT DEGRADATION IN CROHN’S DISEASE MEDIATED BY ALTERED GUT MICROBIOME. THE ENIGMA STUDYZhang, Jingwan, Tang, Xinyi, Hao, Fangjia, Kang, Seungha, Teh, Jing Jie, Trakman, Gina L., Zheng, Jiaying, SUN, Qianru, Liu, Yingzhi, Hamilton, Amy L., O’ Brien, Amy Wilson, Ching, Jessica Y., Sun, Yang, Zhang, Lin, Miao, Yinglei, Chan, Francis K., Sung, Joseph JY, Morrison, Mark, Kamm, Michael A. and Ng, Siew C. (2026). Mo1618 EMULSIFIER POLYSORBATE 80 EXHIBITS DISTINCT DEGRADATION IN CROHN’S DISEASE MEDIATED BY ALTERED GUT MICROBIOME. THE ENIGMA STUDY. Elsevier BV. doi: 10.1016/s0016-5085(26)03057-x |
|
2026 Conference Publication A comparison of diagnostic methodologies for small intestinal bacterial overgrowth: aspirate culture, breath testing and the Atmo capsuleShah, Ayesha, Ghoshal, Uday C., Fairlie, Thomas, Ghoshal, Ujjala, Koloski, Natasha, Lim, Yenkai, Morrison, Mark, Sahu, Shikha, Singh, Madhuri, Spencer, Sean, Gibson, Peter R. and Holtmann, Gerald (2026). Su1303 A COMPARISON OF DIAGNOSTIC METHODOLOGIES FOR SMALL INTESTINAL BACTERIAL OVERGROWTH: ASPIRATE CULTURE, BREATH TESTING AND THE ATMO CAPSULE. Gastrointestinal Endoscopy, 103 (5), S-2458. doi: 10.1016/s0016-5107(26)05746-9 |
|
2026 Conference Publication 729 FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE CROHN’S DISEASE: THE MIRO (MICROBIAL RESTORATION) RANDOMISED PLACEBO-CONTROLLED TRIALFehily, Sasha R., Wright, Emily K., Bogatic, Damjana, O’ Brien, Amy Wilson, Basnayake, Chamara, Stanley, Annalise, Marks, Elise, Russell, Erin, Yuwei, Rong, Gory, Ilana, Ardalan, Zaid, Hamilton, Amy L., Morrison, Mark, Thompson, Alexander, Bryant, Robert V., Costello, Samuel and Kamm, Michael A. (2026). 729 FAECAL MICROBIOTA TRANSPLANTATION FOR ACTIVE CROHN’S DISEASE: THE MIRO (MICROBIAL RESTORATION) RANDOMISED PLACEBO-CONTROLLED TRIAL. Elsevier BV. doi: 10.1016/s0016-5085(26)02372-3 |
|
2026 Conference Publication OP15 Faecal microbiota transplantation for active Crohn's disease: the MIRO (Microbial Restoration) randomised placebo-controlled trialFehily, S., Wright, E. K., Bogatic, D., Wilson-O'brien, A., Basnayake, C., Stanley, A., Marks, E., Russell, E., Rong, Y., Gory,, Ardalan, Z., Hamilton, A., Morrison, M., Thompson, A., Bryant, R., Costello, S. P. and Kamm, M. A. (2026). OP15 Faecal microbiota transplantation for active Crohn's disease: the MIRO (Microbial Restoration) randomised placebo-controlled trial. 21st Congress of the European Crohn’s and Colitis Organisation (ECCO), Stockholm, Sweden, 18–21 February 2026. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/ecco-jcc/jjaf231.015 |
|
2025 Conference Publication Enrichment of putative bacteria-reactive gut-derived IL-17+tissue resident memory helper T cells in arthritic ankles in the SKG mouse model of spondyloarthritisCai, Benjamin, Soon, Megan, Tuong, Zewen Kelvin, Morrison, Mark, Bergot, Anne-Sophie and Thomas, Ranjeny (2025). Enrichment of putative bacteria-reactive gut-derived IL-17+tissue resident memory helper T cells in arthritic ankles in the SKG mouse model of spondyloarthritis. ACR Convergence 2025, Chicago, IL, United States, 24 – 29 October 2025. Hoboken, NJ, United States: John Wiley & Sons. doi: 10.1002/art.43421 |
|
2025 Conference Publication Faecal microbiota transplantation for active Crohn's disease: the MIRO (Microbial Restoration) randomised placebo-controlled trialFehily, Sasha R., Wright, Emily K., Bogatic, Damjana, O'Brien, Amy L. Wilson, Basnayake, Chamara, Stanley, Annalise, Marks, Elise, Russell, Erin, Rong, Yuwei J., Gory, Ilana, Ardalan, Zaid, Hamilton, Amy L., Morrison, Mark, Thompson, Alexander, Bryant, Robert V., Costello, Samuel P. and Kamm, Michael A. (2025). Faecal microbiota transplantation for active Crohn's disease: the MIRO (Microbial Restoration) randomised placebo-controlled trial. World Gastroenterology Organisation and Gastroenterological Society of Australia World Congress of Gastroenterology @ Australian Gastroenterology Week 2025, Melbourne, VIC, Australia, 19-22 September 2025. Richmond, VIC, Australia: John Wiley & Sons. doi: 10.1111/jgh.70044 |
|
2025 Conference Publication Functional Dyspepsia Duodenal Mucosal Associated Microbiota Associations With Mucosal And Peripheral Immune HomeostasisHoedt, Emily C., Burns, Grace L., Kang, Seungha, Bruce, Jessica K., Morrison, Mark, Keely, Simon and Talley, Nicholas J. (2025). Functional Dyspepsia Duodenal Mucosal Associated Microbiota Associations With Mucosal And Peripheral Immune Homeostasis. Digestive Disease Week (DDW) 2025, San Diego, CA United States, 3-6 August 2025. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(25)02885-9 |
|
2025 Conference Publication Gut microbiome signatures discriminate nontuberculous mycobacterial pulmonary disease patients requiring treatment from those with stable diseaseThompson, R., Lim, Y., Goh, F., Blumenthal, A., Morrison, M. and Thomson, R. (2025). Gut microbiome signatures discriminate nontuberculous mycobacterial pulmonary disease patients requiring treatment from those with stable disease. ATS 2025 International Conference, San Francisco, CA USA, 16-21 May 2025. New York, NY USA: American Thoracic Society. doi: 10.1164/ajrccm.2025.211.Abstracts.A3175 |
|
2025 Conference Publication Cloaking antibodies prevent immune detection and destruction of inflammatory Crohn’s microbiota, resulting in treatment resistance: the first description of a central pathogenic mechanismFeng, Wenkang, Tovey-Matthews, Abigail, Schulberg, Julien D., Hamilton, Amy L., Lovett, Grace C., Wright, Emily K., Kamm, Michael A., Morrison, Mark and Wells, Timothy (2025). Cloaking antibodies prevent immune detection and destruction of inflammatory Crohn’s microbiota, resulting in treatment resistance: the first description of a central pathogenic mechanism. Digestive Disease Week (DDW) 2025, San Diego, CA United States, 3-6 August 2025. Philadelphia, PA United States: Elsevier. doi: 10.1016/s0016-5085(25)02172-9 |
